High-throughput screening for small molecule inhibitors of the type-I interferon signaling pathway
文献类型：期刊论文
| 作者 | Yuliantie, Elita2,3,5; Dai, Xinchuan3,5; Yang, Dehua2,3,5 ; Crack, Peter J.1; Wang, Ming-Wei2,3,4,5
|
| 刊名 | ACTA PHARMACEUTICA SINICA B
 |
| 出版日期 | 2018-10 |
| 卷号 | 8期号:6页码:889-899 |
| 关键词 | High-throughput screening Interferon alpha receptor Secreted embryonic alka-line phosphatase JAK-STAT IFN regulatory factor Inhibitor |
| ISSN号 | 2211-3835 |
| DOI | 10.1016/j.apsb.2018.07.005 |
| 文献子类 | Article |
| 英文摘要 | Interferons (IFNs) are cytokines with fundamental roles in resistance to infections, cancer and other diseases. Type-I IFNs, interferon alpha (IFN-alpha) and interferon beta (IFN-beta), act through a shared receptor complex (IFNAR) comprised of IFNAR1 and IFNAR2 subunits. Binding of type-I IFN to IFNAR1 will robustly activate Janus activated kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway. Aberrant activation of the type-I IFN response results in a spectrum of disorders called interferonopathies. The purpose of this research is to develop an assay for high-throughput screening (HTS) of small molecule inhibitors of the type-I IFN signaling pathway. Inhibition of type-I IFN signaling can be beneficial in terms of therapeutic use and understanding the underlying mechanism of action. We report here a HTS campaign with the secreted embryonic alkaline phosphatase (SEAP) reporter gene assay against 32,000 compounds which yielded 25 confirmed hits. These compounds were subsequently characterized for their cytotoxicity, effects on STAT phosphorylation and activities in IFN regulatory factor (IRF) transcription. |
| WOS关键词 | ACTIVATION ; IDENTIFICATION ; TRANSDUCER ; ASSAYS ; CELLS |
| 资助项目 | Shanghai Science and Technology Development Fund[MWW: 15DZ2291600] ; Thousand Talents Program in China[MWW: [2011] ; Australian Research Council Future Fellowship[00000000] ; CAS President's International Fellowship Initiative (PIFI)[00000000] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000451117700005 |
| 出版者 | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/279545]  |
| 专题 | 国家新药筛选中心 |
| 通讯作者 | Wang, Ming-Wei |
| 作者单位 | 1.Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia; 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China; 3.Chinese Acad Sci, Key Lab Receptor Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 4.Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China 5.Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; |
| 推荐引用方式 GB/T 7714 | Yuliantie, Elita,Dai, Xinchuan,Yang, Dehua,et al. High-throughput screening for small molecule inhibitors of the type-I interferon signaling pathway[J]. ACTA PHARMACEUTICA SINICA B,2018,8(6):889-899. |
| APA | Yuliantie, Elita,Dai, Xinchuan,Yang, Dehua,Crack, Peter J.,&Wang, Ming-Wei.(2018).High-throughput screening for small molecule inhibitors of the type-I interferon signaling pathway.ACTA PHARMACEUTICA SINICA B,8(6),889-899. |
| MLA | Yuliantie, Elita,et al."High-throughput screening for small molecule inhibitors of the type-I interferon signaling pathway".ACTA PHARMACEUTICA SINICA B 8.6(2018):889-899. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。